Zoltán Patay Scientific Symposium: Moving Towards Artificial Intelligence in Pediatric Tumor Imaging

Monday, April 3, 2023, 8:00 AM - 5:00 PM, Marlo Thomas Center Lecture Hall, Memphis, TN

PBII Scientific Symposium for Diagnostic Imaging: Machine Learning and Artificial Intelligence

1. Explain what artificial intelligence is and the potential scope of it in the improvement of patient care
2. Describe how to implement artificial intelligence to improve experience, efficiency, and quality of imaging children with pediatric tumors.
3. Identify areas in which artificial intelligence can be implemented for better delivery of clinical care for patients with pediatric tumors.

Registration for this symposium in now open.  At this time, the PBII 2023 Scientific Symposium will be a hybrid event.  

• General Registration (in-person): $200
• Students & Fellows Registration (in-person): $150
• General Registration (virtual): $150
• Students & Fellows (virtual): $100

For questions regarding the symposium, please contact Erin Starnes ([email protected] or 901-595-0465) or Susan Orozco ([email protected]).

 

 

St. Jude Children's Research Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

St. Jude Children’s Research Hospital designates this Live Activity for a maximum of 6.25 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ (6.25 hours), Non-Physician Attendance (6.25 hours)

Hotel information coming soon. 

The faculty for this activity are listed below. Click to view the faculty member's financial disclosure information and bio. 

Mitigation of Relevant Financial Relationships

St Jude Children's Research Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (ie, companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Monday, April 3, 2023